Check out 'The Soloff & Zervanos Show' Podcast on WWDB Talk 860 - Click Here!

Philadelphia Cancer Misdiagnosis Lawyer

While cancer treatments are making advances all the time, the most important way to address this often-fatal disease is through early detection. Colon cancer, prostate cancer, breast cancer, and cervical cancer (among others) may be completely survivable, provided they are recognized in the earliest stages.

As these types of cancer are ignored and misread and treatment is delayed as a result, the likelihood of survival becomes far less likely. A failed or delayed diagnosis can cause premature death, or in a best-case scenario, invasive, painful, and expensive treatment. These treatments can result in loss of income, scarring, and other long-term health complications.

When you or a loved one has been injured because of a delayed or incorrect misdiagnosis, it is important to understand your rights by reaching out to the strongest Philadelphia cancer misdiagnosis lawyer you can find.

An example of our success:

$500,000 to the estate of a gentleman who died as a result of misdiagnosis of his cancer. Soloff & Zervanos was able to prove that his untimely death could have been averted with the proper cancer diagnosis.

Contact a Philadelphia Cancer Misdiagnosis Attorney

Having worked on medical malpractice cases for more than a quarter century, we have a comprehensive knowledge of misdiagnosis cases. We will bring the experience that has obtained tens of millions for clients during our tenure to do everything possible to obtain the compensation you deserve. We know that there is nothing we can do to truly take back the damage of a failed or delayed diagnosis, but we are committed to bolstering accountability from the medical community and helping people heal and recover as best as possible. We encourage you to get in touch.

To schedule a free consultation to discuss your case with one of our Philadelphia cancer misdiagnosis lawyers, contact Soloff & Zervanos, P.C. Phones are answered 24 hours a day.